Berry Corporation (Bry)
NASDAQ:BRY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Berry Corporation (Bry)
NASDAQ:BRY
|
US |
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BRY's stock price target?
Not Available
BRY doesn't have any price targets made by Wall Street professionals.
What is Berry Corporation (Bry)'s Revenue forecast?
Projected CAGR
-4%
For the last 8 years the
compound annual growth rate for
Berry Corporation (Bry)'s revenue is
8%.
The projected
CAGR
for the next 3 years is
-4%.
What is Berry Corporation (Bry)'s Operating Income forecast?
Projected CAGR
-65%
The
compound annual growth rate
of Berry Corporation (Bry)'s operating income for the next 3 years is
-65%.
What is Berry Corporation (Bry)'s Net Income forecast?
Projected CAGR
-57%
The
compound annual growth rate
of Berry Corporation (Bry)'s net income for the next 3 years is
-57%.
